Growth Metrics

Nexalin Technology (NXL) Liabilities and Shareholders Equity (2021 - 2026)

Nexalin Technology's quarterly Liabilities and Shareholders Equity came in at $3.7 million in Q1 2026, up 27.4% year-on-year from $2.9 million in Q1 2025, and down 20.29% quarter-over-quarter from $4.6 million in Q4 2025.

Nexalin Technology has reported Liabilities and Shareholders Equity for 6 years, with the latest figure at $3.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 27.4% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $20.0 million (up 43.58% YoY), and the FY2025 full-year result was $4.6 million, up 9.77% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $3.7 million, down from $4.6 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $8.4 million in Q3 2022, with the low at $1.6 million in Q2 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $4.8 million, with a median of $4.6 million recorded in 2025.
  • Year-over-year, Liabilities and Shareholders Equity soared 886.09% in 2022 and plunged 69.8% in 2024.
  • Tracing NXL's Liabilities and Shareholders Equity over 5 years: stood at $7.4 million in 2022, then sank by 51.13% to $3.6 million in 2023, then climbed by 16.27% to $4.2 million in 2024, then advanced by 9.77% to $4.6 million in 2025, then decreased by 20.29% to $3.7 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $3.7 million (Q1 2026), $4.6 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 3.69 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.69 Mn
Dec 31, 2025 4.64 Mn
Sep 30, 2025 5.13 Mn
Jun 30, 2025 6.56 Mn
Mar 31, 2025 2.90 Mn
Dec 31, 2024 4.22 Mn
Sep 30, 2024 5.26 Mn
Jun 30, 2024 1.56 Mn
Mar 31, 2024 2.83 Mn
Dec 31, 2023 3.63 Mn
Sep 30, 2023 4.43 Mn
Jun 30, 2023 5.18 Mn
Mar 31, 2023 5.93 Mn
Dec 31, 2022 7.43 Mn
Sep 30, 2022 8.35 Mn
Dec 31, 2021 753,698.00